CN106726767A - 一种控油祛痘洗面膏及其制备方法 - Google Patents
一种控油祛痘洗面膏及其制备方法 Download PDFInfo
- Publication number
- CN106726767A CN106726767A CN201611219507.1A CN201611219507A CN106726767A CN 106726767 A CN106726767 A CN 106726767A CN 201611219507 A CN201611219507 A CN 201611219507A CN 106726767 A CN106726767 A CN 106726767A
- Authority
- CN
- China
- Prior art keywords
- parts
- oil control
- acne removal
- cleansing cream
- oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 208000002874 Acne Vulgaris Diseases 0.000 title claims abstract description 99
- 206010000496 acne Diseases 0.000 title claims abstract description 99
- 239000006071 cream Substances 0.000 title claims abstract description 62
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- 239000003921 oil Substances 0.000 claims abstract description 100
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 37
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 33
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 claims abstract description 31
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 28
- 239000008367 deionised water Substances 0.000 claims abstract description 22
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 22
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims abstract description 19
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 claims abstract description 19
- 229940070800 myristoyl glutamate Drugs 0.000 claims abstract description 19
- 235000009024 Ceanothus sanguineus Nutrition 0.000 claims abstract description 18
- 240000003553 Leptospermum scoparium Species 0.000 claims abstract description 18
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 18
- 229920002125 Sokalan® Polymers 0.000 claims abstract description 18
- 229960001631 carbomer Drugs 0.000 claims abstract description 18
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 claims abstract description 18
- 235000011187 glycerol Nutrition 0.000 claims abstract description 18
- 229920001285 xanthan gum Polymers 0.000 claims abstract description 18
- AXTGDCSMTYGJND-UHFFFAOYSA-N 1-dodecylazepan-2-one Chemical compound CCCCCCCCCCCCN1CCCCCC1=O AXTGDCSMTYGJND-UHFFFAOYSA-N 0.000 claims abstract description 17
- 229920002385 Sodium hyaluronate Polymers 0.000 claims abstract description 17
- 229940010747 sodium hyaluronate Drugs 0.000 claims abstract description 17
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims abstract description 17
- 239000000341 volatile oil Substances 0.000 claims abstract description 17
- 235000010388 propyl gallate Nutrition 0.000 claims abstract description 15
- 239000000473 propyl gallate Substances 0.000 claims abstract description 15
- 229940075579 propyl gallate Drugs 0.000 claims abstract description 15
- 238000002156 mixing Methods 0.000 claims description 33
- 238000003756 stirring Methods 0.000 claims description 26
- 239000000203 mixture Substances 0.000 claims description 16
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 claims description 13
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 claims description 12
- WACBUPFEGWUGPB-MIUGBVLSSA-N calycosin-7-O-beta-D-glucoside Chemical compound C1=C(O)C(OC)=CC=C1C1=COC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=CC=C2C1=O WACBUPFEGWUGPB-MIUGBVLSSA-N 0.000 claims description 12
- WACBUPFEGWUGPB-UHFFFAOYSA-N calycosin-7-O-beta-D-glucoside Natural products C1=C(O)C(OC)=CC=C1C1=COC2=CC(OC3C(C(O)C(O)C(CO)O3)O)=CC=C2C1=O WACBUPFEGWUGPB-UHFFFAOYSA-N 0.000 claims description 11
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 10
- 239000011675 vitamin B5 Substances 0.000 claims description 10
- 239000012467 final product Substances 0.000 claims description 5
- 229960005150 glycerol Drugs 0.000 claims description 5
- -1 glycerol stearate Ester Chemical class 0.000 claims description 3
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 claims 1
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 claims 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N beta-monoglyceryl stearate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims 1
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 claims 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 claims 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 claims 1
- 235000008696 isoflavones Nutrition 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 13
- 239000000126 substance Substances 0.000 abstract description 7
- 238000004140 cleaning Methods 0.000 abstract description 6
- 239000006260 foam Substances 0.000 abstract description 5
- 239000008239 natural water Substances 0.000 abstract description 4
- 230000001815 facial effect Effects 0.000 abstract description 3
- 230000000052 comparative effect Effects 0.000 description 16
- 239000000047 product Substances 0.000 description 15
- 238000012360 testing method Methods 0.000 description 10
- 229910001868 water Inorganic materials 0.000 description 7
- 235000021355 Stearic acid Nutrition 0.000 description 4
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 4
- 239000008117 stearic acid Substances 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 244000046146 Pueraria lobata Species 0.000 description 3
- 235000010575 Pueraria lobata Nutrition 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- 230000000149 penetrating effect Effects 0.000 description 3
- 244000060011 Cocos nucifera Species 0.000 description 2
- 235000013162 Cocos nucifera Nutrition 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- FATBGEAMYMYZAF-KTKRTIGZSA-N oleamide Chemical compound CCCCCCCC\C=C/CCCCCCCC(N)=O FATBGEAMYMYZAF-KTKRTIGZSA-N 0.000 description 2
- FATBGEAMYMYZAF-UHFFFAOYSA-N oleicacidamide-heptaglycolether Natural products CCCCCCCCC=CCCCCCCCC(N)=O FATBGEAMYMYZAF-UHFFFAOYSA-N 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 210000002374 sebum Anatomy 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 230000008719 thickening Effects 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010048461 Genital infection Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 241000208181 Pelargonium Species 0.000 description 1
- 241000405414 Rehmannia Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 241001122767 Theaceae Species 0.000 description 1
- 240000004922 Vigna radiata Species 0.000 description 1
- 235000010721 Vigna radiata var radiata Nutrition 0.000 description 1
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 241000589636 Xanthomonas campestris Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 210000004413 cardiac myocyte Anatomy 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000008233 hard water Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 231100000017 mucous membrane irritation Toxicity 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 235000020737 peppermint extract Nutrition 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 230000008635 plant growth Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- 230000037384 skin absorption Effects 0.000 description 1
- 231100000274 skin absorption Toxicity 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- ZNYIJXQYUNSKDX-NTISSMGPSA-M sodium;hydron;(2s)-2-(tetradecanoylamino)pentanedioate Chemical compound [Na+].CCCCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC(O)=O ZNYIJXQYUNSKDX-NTISSMGPSA-M 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 238000009834 vaporization Methods 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 239000002888 zwitterionic surfactant Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A61K8/442—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8147—Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/008—Preparations for oily skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
Abstract
本发明属于日化用品技术领域，具体涉及一种控油祛痘洗面膏及其制备方法。本发明提供的控油祛痘洗面膏，包括以下组分及其重量份数：甘油4‑7份，椰油酰胺丙基甜菜碱7‑12份，肉豆蔻酰谷氨酸钠20‑30份，没食子酸丙酯0.02‑0.06份，硬脂酸甘油酯3‑5份，卡波姆1‑2份，透明质酸钠4‑8份，黄原胶1‑3份，氮酮0.02‑0.05份，茶树精油0.05‑0.08份，控油祛痘剂0.8‑1.5份和去离子水26‑38份。本发明提供的控油祛痘洗面膏安全、温和，不刺激，泡沫细腻柔滑，有效清洁肌肤的同时，带走面部多余油脂及污垢，并且不破坏肌肤天然的水油平衡，本发明提供的控油祛痘洗面膏具有显著的控油祛痘效果。
Description
技术领域
本发明属于日化用品技术领域，具体涉及一种控油祛痘洗面膏及其制备方法。
背景技术
现在的环境变差，空气中尘埃多。洗面不彻底皮肤易产生角质层肥厚、粉刺、皮肤暗沉等问题，进而影响保养品的吸收。也就是说如果皮肤的多余角质、皮脂及外来污垢没有被彻底地清除掉就涂上保养品，那些产品也会因为无法很好的被皮肤吸收，而变成污垢残留在肌肤上。通过洗面能够使得皮肤处于尽可能无污染和无侵害的状态中，为皮肤提供良好的生理条件。清洁皮肤也是对皮肤很好的调整和放松过程，在这个过程中，可以有效地激发皮肤活力，使得毛孔充分通透充分发挥皮肤健康和正常的吸收、呼吸、排泄功能，保持皮肤良好的新陈代谢状态。
中国专利申请CN103705391A公开了一种天然去痘印去黑头美白嫩肤温和洗面膏及其制备方法，包括的成分及相应的重量百分比是：白糖30-50％、月桂酸单甘油酯5-10％、表面活性剂组合物16-35％，其余是水。中国专利申请CN102274137A公开了一种绿色营养洗面膏，其成分由茶籽粉、天竺葵、杏仁、绿豆、熟地黄、羧酸甲基纤维素组成。
目前，市场上的洗面产品种类繁多，有些洗面产品的原理是利用其碱性将我们皮肤上的油污、汗液等清除掉。但因其碱性过强因而会将皮肤上的保护皮脂膜全部清除，所以使用后皮肤觉得干涩、无光滑且还会刺激肌肤，长期使用对皮肤的伤害很大。另外，现有的洗面产品控油祛痘效果不理想。
发明内容
针对现有技术的不足，本发明的目的在于提供一种控油祛痘洗面膏及其制备方法。本发明提供的控油祛痘洗面膏安全、温和，不刺激，泡沫细腻柔滑，有效清洁肌肤的同时，带走面部多余油脂及污垢，并且不破坏肌肤天然的水油平衡，本发明提供的控油祛痘洗面膏具有显著的控油祛痘效果。
本发明的技术方案是：
一种控油祛痘洗面膏，包括以下组分及其重量份数：
甘油4-7份，椰油酰胺丙基甜菜碱7-12份，肉豆蔻酰谷氨酸钠20-30份，没食子酸丙酯0.02-0.06份，硬脂酸甘油酯3-5份，卡波姆1-2份，透明质酸钠4-8份，黄原胶1-3份，氮酮0.02-0.05份，茶树精油0.05-0.08份，控油祛痘剂0.8-1.5份和去离子水26-38份。
进一步地，所述控油祛痘洗面膏包括以下组分及其重量份数：
甘油6份，椰油酰胺丙基甜菜碱9份，肉豆蔻酰谷氨酸钠25份，没食子酸丙酯0.04份，硬脂酸甘油酯4份，卡波姆1.3份，透明质酸钠7份，黄原胶2份，氮酮0.03份，茶树精油0.06份，控油祛痘剂0.9份和去离子水35份。
进一步地，所述控油祛痘剂由维生素B5、毛蕊异黄酮苷和葛根素按重量比2-4∶5-8∶7-9组成。
进一步地，所述控油祛痘剂由维生素B5、毛蕊异黄酮苷和葛根素按重量比3∶7∶8组成。
另外，本发明还提供了所述控油祛痘洗面膏的制备方法，包括以下步骤：
S1取一半量的去离子水，加入椰油酰胺丙基甜菜碱、肉豆蔻酰谷氨酸钠和硬脂酸甘油酯，搅拌，搅拌速度为400-500r/min，搅拌时间为12-20分钟，加热至70-90℃，恒温搅拌40-50分钟，得A相；
S2将剩余的去离子水加热至70-90℃，加入甘油、卡波姆、透明质酸钠、黄原胶和氮酮，恒温搅拌，搅拌速度为350-450r/min，搅拌时间为1-2小时，得B相；
S3将步骤S1所得A相加入到步骤S2所得B相中，搅拌，搅拌速度为700-800r/min，搅拌时间为15-20分钟，待温度降至45℃时，加入控油祛痘剂，搅拌均匀，待温度降至40℃时，加入没食子酸丙酯和茶树精油，搅拌均匀，即得。
进一步地，所述步骤S1搅拌速度为450r/min。
进一步地，所述步骤S1搅拌时间为18分钟。
进一步地，所述步骤S1加热至85℃。
进一步地，所述步骤S1恒温搅拌46分钟。
进一步地，所述步骤S2将剩余的去离子水加热至85℃。
进一步地，所述步骤S2搅拌速度为380r/min。
进一步地，所述步骤S2搅拌时间为1.5小时。
进一步地，所述步骤S3搅拌速度为760r/min。
进一步地，所述步骤S3搅拌时间为18分钟。
本发明所用主要原料的作用：
椰油酰胺丙基甜菜碱：CAS号：86438-79-1，分子式：C19H38N2O3，分子量：342.52。椰油酰胺丙基甜菜碱是一种两性离子表面活性剂，在酸性及碱性条件下均具有优良的稳定性，刺激性小，易溶于水，对酸碱稳定，泡沫多，去污力强，具有优良的增稠性、柔软性、杀菌性、抗静电性、抗硬水性。
肉豆蔻酰谷氨酸钠：CAS号：38517-37-2，分子式：C19H34NNaO5，分子量：379.46673。肉豆蔻酰谷氨酸钠是一种超温和的氨基酸类表面活性剂，对皮肤和粘膜刺激性极低，不洗去皮肤保湿成分，用后不干燥、不紧绷。
没食子酸丙酯：CAS号：121-79-9，分子式C10H12O5，分子量212.21。没食子酸丙酯广泛用于食品工业，医药制剂中，是一种优良的油脂抗氧化剂，用于化妆品和用作防紫外线照射的抑制剂等。
硬脂酸甘油酯：CAS号：11099-07-3，分子式：C12H24O4。用途：在食品或化妆品中作为乳化剂和表面活性剂。
卡波姆：CAS号：9003-01-4。卡波姆有增稠、悬浮等重要用途，稳定性好，广泛应用于乳液、膏霜、凝胶中。
透明质酸钠：CAS号：9067-32-7，分子式：C28H44N2O23·Na，分子量：799.6366。主要用途：化妆品类高效的锁水保湿剂和肌肤修复基团，提升防晒产品的SPF，赋予产品水润嫩滑的肤感；致肌肤，长久保湿，防止脱水，组织细胞再生。
黄原胶：CAS号：11138-66-2，分子式：C35H49O2。黄原胶是由糖类经黄单胞杆菌发酵，产生的胞外微生物多糖。由于它的大分子特殊结构和胶体特性，而具有多种功能，可作为乳化剂、稳定剂、凝胶增稠剂、浸润剂、膜成型剂等。
氮酮：CAS号：59227-89-3，分子式：C18H35NO，分子量：281.48。用作渗透剂，用于化妆品中各类膏霜及发用品；用作外用药物涂抹、按摩的促渗剂；用于农药，作为植物生长调节剂的促吸剂及杀菌、杀虫剂的促渗剂；此外，还可用于皮革及印染等领域的着色促进剂。
茶树精油：CAS号：68647-73-4。茶树精油为茶树的提取物。具有杀菌消炎，收敛毛孔，治疗伤风感冒、咳嗽、鼻炎、哮喘，改善痛经、月经不调及生殖器感染。适用于油性及粉刺皮肤，治疗化脓伤口及灼伤、晒伤、香港脚及头屑。使头脑清醒，恢复活力，抗沮丧。
维生素B5：CAS号：137-08-6。主要功能：制造及更新身体组织，帮助伤口愈合，制造抗体，抵抗传染病，防止疲劳，帮助抗压，缓和多种抗生素副作用及毒素，舒缓恶心症状。
毛蕊异黄酮苷：CAS号：20633-67-4，分子式：C22H22NO10，分子量：446.40。毛蕊异黄酮苷具有抗氧化，抗辐射，抗癌的作用。
葛根素：CAS号：3681-99-0，分子式：C21H20O9，分子量：416.38。葛根素来源为豆科植物葛根，野葛根。葛根素具有提高免疫，增强心肌收缩力，保护心肌细胞，降低血压，抗血小板聚集等作用。
本发明提供的控油祛痘洗面膏由甘油、椰油酰胺丙基甜菜碱、肉豆蔻酰谷氨酸钠、没食子酸丙酯、硬脂酸甘油酯和控油祛痘剂等原料制备而成。在本发明控油祛痘洗面膏中，甘油与本发明中的其他成分协同作用，提高制备的产品的保湿性，同时能去除皮肤的油腻。在本发明控油祛痘洗面膏中，肉豆蔻酰谷氨酸钠为阴离子表面活性剂，它与本发明中的椰油酰胺丙基甜菜碱等成分配伍，使制备的产品具有优异的发泡性能，使用制备的洗面膏洗脸后令皮肤有柔软滋润的感觉。在本发明控油祛痘洗面膏中，没食子酸丙酯用作抗氧化剂。在本发明控油祛痘洗面膏中，卡波姆和黄原胶主要用作增稠剂、乳化剂和稳定剂。在本发明控油祛痘洗面膏中，透明质酸钠能在皮肤表面形成水化膜，可使角质层水合软化，令皮肤柔软光滑、细腻娇嫩，与本发明中的其他成分协同作用，提高制备的产品的保湿性，使用本发明所得产品后，提高皮肤的光滑感和湿润感，对皮肤起到保护作用。在本发明控油祛痘洗面膏中，氮酮主要用作皮肤渗透剂，可帮助皮肤吸收营养成分。
本发明提供的控油祛痘洗面膏配方合理，使用安全、无刺激，通过各种成分的协同作用，能够温和清除皮肤污垢，温和洁面的同时保护面部天然锁水屏障，而不破坏皮肤天然保湿层，能够深层净化肌肤，带走面部多余油脂及污垢，具有显著的控油祛痘效果。
与现有技术相比，本发明提供的控油祛痘洗面膏具有以下优势：
(1)本发明提供的控油祛痘洗面膏安全、温和，不刺激，温和洁面的同时保护面部天然锁水屏障，令肌肤清透水润，倍感舒展。
(2)本发明提供的控油祛痘洗面膏泡沫细腻柔滑，有效清洁肌肤的同时，带走面部多余油脂及污垢，具有显著的控油祛痘效果。
(3)本发明提供的控油祛痘洗面膏能够有效清洁毛孔，净化肌肤，可以改善皮肤营养代谢，使皮肤柔嫩光滑、增加弹性。
具体实施方式
以下通过具体实施方式的描述对本发明作进一步说明，但这并非是对本发明的限制，本领域技术人员根据本发明的基本思想，可以做出各种修改或改进，但是只要不脱离本发明的基本思想，均在本发明的范围之内。
实施例1、一种控油祛痘洗面膏
所述控油祛痘洗面膏包括以下组分及其重量份数(每份为2200g)：
甘油4份，椰油酰胺丙基甜菜碱7份，肉豆蔻酰谷氨酸钠20份，没食子酸丙酯0.02份，硬脂酸甘油酯3份，卡波姆1份，透明质酸钠4份，黄原胶1份，氮酮0.02份，茶树精油0.05份，控油祛痘剂0.8份和去离子水26份；所述控油祛痘剂由维生素B5、毛蕊异黄酮苷和葛根素按重量比2∶8∶9组成。
制备方法：
S1取一半量的去离子水，加入椰油酰胺丙基甜菜碱、肉豆蔻酰谷氨酸钠和硬脂酸甘油酯，搅拌，搅拌速度为400r/min，搅拌时间为12分钟，加热至70℃，恒温搅拌40分钟，得A相；
S2将剩余的去离子水加热至70℃，加入甘油、卡波姆、透明质酸钠、黄原胶和氮酮，恒温搅拌，搅拌速度为350r/min，搅拌时间为1小时，得B相；
S3将步骤S1所得A相加入到步骤S2所得B相中，搅拌，搅拌速度为700r/min，搅拌时间为15分钟，待温度降至45℃时，加入控油祛痘剂，搅拌均匀，待温度降至40℃时，加入没食子酸丙酯和茶树精油，搅拌均匀，即得。
实施例2、一种控油祛痘洗面膏
所述控油祛痘洗面膏包括以下组分及其重量份数(每份为2200g)：
甘油7份，椰油酰胺丙基甜菜碱12份，肉豆蔻酰谷氨酸钠30份，没食子酸丙酯0.06份，硬脂酸甘油酯5份，卡波姆2份，透明质酸钠8份，黄原胶3份，氮酮0.05份，茶树精油0.08份，控油祛痘剂1.5份和去离子水38份；所述控油祛痘剂由维生素B5、毛蕊异黄酮苷和葛根素按重量比4∶5∶7组成。
制备方法：
S1取一半量的去离子水，加入椰油酰胺丙基甜菜碱、肉豆蔻酰谷氨酸钠和硬脂酸甘油酯，搅拌，搅拌速度为500r/min，搅拌时间为20分钟，加热至90℃，恒温搅拌50分钟，得A相；
S2将剩余的去离子水加热至90℃，加入甘油、卡波姆、透明质酸钠、黄原胶和氮酮，恒温搅拌，搅拌速度为450r/min，搅拌时间为2小时，得B相；
S3将步骤S1所得A相加入到步骤S2所得B相中，搅拌，搅拌速度为800r/min，搅拌时间为20分钟，待温度降至45℃时，加入控油祛痘剂，搅拌均匀，待温度降至40℃时，加入没食子酸丙酯和茶树精油，搅拌均匀，即得。
实施例3、一种控油祛痘洗面膏
所述控油祛痘洗面膏包括以下组分及其重量份数(每份为2200g)：
甘油6份，椰油酰胺丙基甜菜碱9份，肉豆蔻酰谷氨酸钠25份，没食子酸丙酯0.04份，硬脂酸甘油酯4份，卡波姆1.3份，透明质酸钠7份，黄原胶2份，氮酮0.03份，茶树精油0.06份，控油祛痘剂0.9份和去离子水35份；所述控油祛痘剂由维生素B5、毛蕊异黄酮苷和葛根素按重量比3∶7∶8组成。
制备方法：
S1取一半量的去离子水，加入椰油酰胺丙基甜菜碱、肉豆蔻酰谷氨酸钠和硬脂酸甘油酯，搅拌，搅拌速度为450r/min，搅拌时间为18分钟，加热至85℃，恒温搅拌46分钟，得A相；
S2将剩余的去离子水加热至85℃，加入甘油、卡波姆、透明质酸钠、黄原胶和氮酮，恒温搅拌，搅拌速度为380r/min，搅拌时间为1.5小时，得B相；
S3将步骤S1所得A相加入到步骤S2所得B相中，搅拌，搅拌速度为760r/min，搅拌时间为18分钟，待温度降至45℃时，加入控油祛痘剂，搅拌均匀，待温度降至40℃时，加入没食子酸丙酯和茶树精油，搅拌均匀，即得。
对比例1、一种控油祛痘洗面膏
所述控油祛痘洗面膏包括以下组分及其重量份数(每份为2200g)：
甘油6份，椰油酰胺丙基甜菜碱9份，肉豆蔻酰谷氨酸钠25份，没食子酸丙酯0.04份，硬脂酸甘油酯4份，卡波姆1.3份，透明质酸钠7份，黄原胶2份，氮酮0.03份，茶树精油0.06份，控油祛痘剂0.9份和去离子水35份；所述控油祛痘剂由毛蕊异黄酮苷和葛根素按重量比1∶1组成。
制备方法与实施例3类似。
与实施例3不同的是，所述控油祛痘剂由毛蕊异黄酮苷和葛根素按重量比1∶1组成。
对比例2、一种控油祛痘洗面膏
所述控油祛痘洗面膏包括以下组分及其重量份数(每份为2200g)：
甘油6份，椰油酰胺丙基甜菜碱9份，肉豆蔻酰谷氨酸钠25份，没食子酸丙酯0.04份，硬脂酸甘油酯4份，卡波姆1.3份，透明质酸钠7份，黄原胶2份，氮酮0.03份，茶树精油0.06份，控油祛痘剂0.9份和去离子水35份；所述控油祛痘剂由维生素B5、毛蕊异黄酮苷和葛根素按重量比1∶1∶1组成。
制备方法与实施例3类似。
与实施例3不同的是，所述控油祛痘剂由维生素B5、毛蕊异黄酮苷和葛根素按重量比1∶1∶1组成。
试验例一、控油祛痘洗面膏的的卫生、感官和理化指标性能测试试验
1、试验材料：实施例1、实施例2、实施例3、对比例1和对比例2制备的控油祛痘洗面膏。
2、试验方法：参照中华人民共和国国家标准GB/T29680-2013《洗面奶、洗面膏》的相关标准，测试实施例1、实施例2、实施例3、对比例1和对比例2制备的控油祛痘洗面膏的感官指标、理化指标和卫生指标。
3、试验结果：
感官指标、理化指标和卫生指标测试结果如表1所示。
表1：控油祛痘洗面膏的感官指标、理化指标和卫生指标测试结果
从表1可以看出，本发明实施例1-3制得的控油祛痘洗面膏，以及对比例1和对比例2制得的控油祛痘洗面膏的感官指标、理化指标以及卫生指标均符合国家标准。
试验例二、控油祛痘洗面膏的控油祛痘效果
1、试验材料：实施例1、实施例2、实施例3、对比例1和对比例2制备的控油祛痘洗面膏。
2、试验对象：选取150名试验者，年龄在20-48岁之间，受试者符合试验者志愿入选标准。
3、试验方法：
选取150位油性皮肤及中、轻度粉刺试验者，试验者无严重系统及免疫疾病。随机将试验者分为五组，分别为实施例1组、实施例2组、实施例3组、对比例1组和对比例2组，每组30人，各组受试者在性别、年龄等一般情况方面无显著性差异。五组试验者分别试用实施例1、实施例2、实施例3、对比例1和对比例2制备的控油祛痘洗面膏。早晚各用一次，连续使用两周，试验期间不使用其他类似产品。
效果判断标准：显效：皮肤出油、粉刺症状完全消失或明显改善；好转：皮肤出油、粉刺症状改善；无效：症状无变化。
4、试验结果：
结果如表2所示。
表2：控油祛痘洗面膏的控油祛痘效果
由表2可知，与对比例1组和对比例2组相比，实施例1组、实施例2组和实施例3组的皮肤出油、粉刺症状得到显著改善。这说明，本发明制备的控油祛痘洗面膏能有效控油、祛痘。且受试者反应，本发明控油祛痘洗面膏安全、温和，不刺激，使用后肌肤清透水润，倍感舒展。
Claims (10)
1.一种控油祛痘洗面膏，其特征在于，包括以下组分及其重量份数：
甘油4-7份，椰油酰胺丙基甜菜碱7-12份，肉豆蔻酰谷氨酸钠20-30份，没食子酸丙酯0.02-0.06份，硬脂酸甘油酯3-5份，卡波姆1-2份，透明质酸钠4-8份，黄原胶1-3份，氮酮0.02-0.05份，茶树精油0.05-0.08份，控油祛痘剂0.8-1.5份和去离子水26-38份。
2.如权利要求1所述的控油祛痘洗面膏，其特征在于，包括以下组分及其重量份数：
甘油6份，椰油酰胺丙基甜菜碱9份，肉豆蔻酰谷氨酸钠25份，没食子酸丙酯0.04份，硬脂酸甘油酯4份，卡波姆1.3份，透明质酸钠7份，黄原胶2份，氮酮0.03份，茶树精油0.06份，控油祛痘剂0.9份和去离子水35份。
3.如权利要求1或2所述的控油祛痘洗面膏，其特征在于，所述控油祛痘剂由维生素B5、毛蕊异黄酮苷和葛根素按重量比2-4∶5-8∶7-9组成。
4.如权利要求3所述的控油祛痘洗面膏，其特征在于，所述控油祛痘剂由维生素B5、毛蕊异黄酮苷和葛根素按重量比3∶7∶8组成。
5.如权利要求1-4任一所述的控油祛痘洗面膏的制备方法，其特征在于，包括以下步骤：
S1取一半量的去离子水，加入椰油酰胺丙基甜菜碱、肉豆蔻酰谷氨酸钠和硬脂酸甘油酯，搅拌，搅拌速度为400-500r/min，搅拌时间为12-20分钟，加热至70-90℃，恒温搅拌40-50分钟，得A相；
S2将剩余的去离子水加热至70-90℃，加入甘油、卡波姆、透明质酸钠、黄原胶和氮酮，恒温搅拌，搅拌速度为350-450r/min，搅拌时间为1-2小时，得B相；
S3将步骤S1所得A相加入到步骤S2所得B相中，搅拌，搅拌速度为700-800r/min，搅拌时间为15-20分钟，待温度降至45℃时，加入控油祛痘剂，搅拌均匀，待温度降至40℃时，加入没食子酸丙酯和茶树精油，搅拌均匀，即得。
6.如权利要求5所述的控油祛痘洗面膏的制备方法，其特征在于，所述步骤S1搅拌速度为450r/min。
7.如权利要求5所述的控油祛痘洗面膏的制备方法，其特征在于，所述步骤S1搅拌时间为18分钟。
8.如权利要求5所述的控油祛痘洗面膏的制备方法，其特征在于，所述步骤S1加热至85℃。
9.如权利要求5所述的控油祛痘洗面膏的制备方法，其特征在于，所述步骤S1恒温搅拌46分钟。
10.如权利要求5所述的控油祛痘洗面膏的制备方法，其特征在于，所述步骤S2将剩余的去离子水加热至85℃。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611219507.1A CN106726767A (zh) | 2016-12-26 | 2016-12-26 | 一种控油祛痘洗面膏及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611219507.1A CN106726767A (zh) | 2016-12-26 | 2016-12-26 | 一种控油祛痘洗面膏及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106726767A true CN106726767A (zh) | 2017-05-31 |
Family
ID=58925199
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201611219507.1A Withdrawn CN106726767A (zh) | 2016-12-26 | 2016-12-26 | 一种控油祛痘洗面膏及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106726767A (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112300234A (zh) * | 2020-10-26 | 2021-02-02 | 上海珈凯生物科技有限公司 | 一种异黄酮的提取方法及其提取得到的异黄酮和应用 |
| CN115607465A (zh) * | 2022-11-01 | 2023-01-17 | 周嘉奇 | 一种控油保湿爽肤水及其制备方法 |
-
2016
- 2016-12-26 CN CN201611219507.1A patent/CN106726767A/zh not_active Withdrawn
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112300234A (zh) * | 2020-10-26 | 2021-02-02 | 上海珈凯生物科技有限公司 | 一种异黄酮的提取方法及其提取得到的异黄酮和应用 |
| CN115607465A (zh) * | 2022-11-01 | 2023-01-17 | 周嘉奇 | 一种控油保湿爽肤水及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH1036283A (ja) | 線維芽細胞増殖促進剤 | |
| JPH1036279A (ja) | 植物抽出物含有線維芽細胞増殖促進剤 | |
| CN106333885A (zh) | 一种植物提取物及眼部精华液 | |
| CN105902418A (zh) | 一种仿皮脂基质、包含仿皮脂基质的外用制剂及其应用 | |
| CN107303253A (zh) | 一种用于受损肌肤的修复剂及其制备方法 | |
| CN108685769A (zh) | 一种复方中药乌发防脱洗发水及其制备方法 | |
| KR101810229B1 (ko) | 티트리 잎 미세침 분말을 함유하는 여드름 개선용 화장료 조성물 | |
| CN109260054A (zh) | 一种植物防蚊止痒膏及其制备方法 | |
| KR101412713B1 (ko) | 검버섯 및 잔주름 개선기능을 갖는 생약숙성탕액을 이용한 천연비누 및 그 제조방법 | |
| CN106562921A (zh) | 一种含有中药活性物质和茶树精油液体口腔用组合物 | |
| CN105878114A (zh) | 一种清爽保湿补水美容液的配方 | |
| CN107970140A (zh) | 一种含有鳄鱼油的祛疤组合物及其应用 | |
| KR102248405B1 (ko) | 넉줄고사리 추출물 및 편백잎 추출물을 유효성분으로 포함하는 피부 보습용 화장료 조성물 | |
| CN106726767A (zh) | 一种控油祛痘洗面膏及其制备方法 | |
| KR20170079337A (ko) | 피부 온도 감응형 기능성 하이드로 겔을 이용한 얼굴윤곽 개선용 패치 및 그 제조방법 | |
| KR101807784B1 (ko) | 피부 온도 감응형 기능성 하이드로 겔을 이용한 발 뒤꿈치 각질 완화용 패치 및 그 제조방법 | |
| KR101835799B1 (ko) | 프로폴리스를 유효성분으로 함유하는 화장품 조성물 및 상기 조성물을 포함하는 화장품 | |
| CN106333918A (zh) | 凹凸棒晒后修护面霜 | |
| CN107955756B (zh) | 一种手工皂及其制备方法 | |
| KR102248406B1 (ko) | 넉줄고사리 추출물, 편백잎 추출물 및 초피나무열매 추출물을 유효성분으로 포함하는 피부 보습용 화장료 조성물 | |
| KR102459024B1 (ko) | 버베나 히브리다, 시클라멘 및 세인트폴리아의 혼합 추출물을 포함하는 피부 보습용 화장료 조성물 | |
| CN107802516A (zh) | 一种长效保湿护肤精华液 | |
| CN112716838A (zh) | 一种玫瑰精油修复紧致眼部精华液及其制备方法 | |
| CN111973502A (zh) | 一种清透气垫cc霜及其制备方法 | |
| CN100525744C (zh) | 修复霜 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20170531 |
|
| WW01 | Invention patent application withdrawn after publication |